Rubinstein Linda M 4
4 · Adverum Biotechnologies, Inc. · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2023-08-03+850,000→ 850,000 totalExercise: $2.10Exp: 2033-08-02→ Common Stock (850,000 underlying)
Footnotes (1)
- [F1]Non-Statutory Stock Option to purchase 850,000 shares granted under the Issuer's 2014 Equity Incentive Plan (the "Plan"), 25% vesting 6 months from the Reporting Person's first day of employment with the Issuer, and 17,708.33 shares vesting monthly thereafter for the next 36 months, subject to the Reporting Person's continued service with the Issuer on each such vesting date.